CH Term (R4)
3.3.0-ci-build - ci-build
CH Term (R4)
3.3.0-ci-build - ci-build
CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.3.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm | Version: 3.3.0-ci-build | |||
| Active as of 2025-11-21 | Computable Name: ImmunGlobulineToTargetDiseaseMapping | |||
Copyright/Legal: This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org. |
||||
Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets
Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to CH VACD Target disease and illnesses undergone for immunization
Group 1 Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to SNOMED CT (all versions)
| Source Concept Details | Relationship | Target Concept Details | ||
| Codes from CH VACD Swissmedic Authorized Immunoglobulin Codes | Codes from SNOMED CT (all versions) | |||
| 00687-01 | Berirab 2 ml, Injektionslösung | is related to | 14168008 | Rabies (disorder) |
| 00687-02 | Berirab 5 ml, Injektionslösung | is related to | 14168008 | Rabies (disorder) |
| 69039-02 | Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 69039-01 | Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 68222-01 | Cutaquig 165 mg/ml, Injektionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 65992-01 | Cuvitru 200 mg/ml, Injektionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 00506-02 | Cytotect CP Biotest, Infusionslösung | is related to | 28944009 | Infection caused by Cytomegalovirus (disorder) |
| 00701-02 | Gammanorm, Injektionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 16318001000119107 | Hypogammaglobulinemia due to multiple myeloma (disorder) | ||
| 00668-01 | Gamunex 10%, solution pour injection intraveineuse | is related to | 14189004 | Measles (disorder) |
| 00488-02 | Hepatect CP, Infusionslösung | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 00674-01 | Hepatitis-B-Immunglobulin Behring, Injektionslösung | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 66410-01 | Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 61547-01 | Hizentra, Injektionslösung zur s.c. Anwendung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66684-01 | HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 58157-01 | Ig Vena Kedrion 50 g/I, solution pour infusion | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 62913-01 | Intratect 10%, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 57676-01 | Intratect 5%, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-03 | Iqymune 10g/100ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-04 | Iqymune 20g/200ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-01 | Iqymune 2g/20ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 66332-02 | Iqymune 5g/50ml, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 57469-01 | Kiovig, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 60323-01 | Octagam 10 %, Lösung zur intravenösen Anwendung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 58314-01 | Privigen, Infusionslösung | is related to | 58606001 | Primary immune deficiency disorder (disorder) |
| is related to | 33286000 | Secondary immune deficiency disorder (disorder) | ||
| 53609-02 | Rhophylac 300, Injektionslösung | is related to | 165746003 | RhD negative (finding) |
| 65695-02 | Synagis 100 mg/1 ml, Injektionslösung | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 65695-01 | Synagis 50 mg/0.5 ml, Injektionslösung | is related to | 55735004 | Respiratory syncytial virus infection (disorder) |
| 00673-02 | Tetagam P, Injektionslösung | is related to | 76902006 | Tetanus (disorder) |
| 59374-01 | Uman Big 180 UI/1 ml, solution pour injection intramusculaire | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 59374-02 | Uman Big 540 UI/3 ml, solution pour injection intramusculaire | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 59451-01 | Varitect CP, Lösung zur intravenösen Injektion | is related to | 38907003 | Varicella (disorder) |
| 59373-02 | Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 59373-01 | Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse | is related to | 66071002 | Viral hepatitis type B (disorder) |
| 68471-01 | Xevudy, Konzentrat zur Herstellung einer Infusionslösung | is related to | 840539006 | Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) |
| 66344-01 | Zinplava, Konzentrat zur Herstellung einer Infusionslösung | is related to | 56688005 | Clostridial infection (disorder) |
| 61639-01 | Zutectra, Injektionslösung | is related to | 66071002 | Viral hepatitis type B (disorder) |